Company Filing History:
1 out of 1,314 
1 out of 5,499 
Years Active: 2014
Title: The Innovative Contributions of Lois Myeroff
Introduction
Lois Myeroff is a notable inventor based in Chardon, Ohio, recognized for her significant contributions to the field of cancer research. With a focus on the molecular mechanisms underlying colorectal cancer, she has made strides in understanding the role of DNA methylation in neoplasia.
Latest Patents
Myeroff holds a patent titled "Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer." This application describes methods and compositions for detecting and treating C6Orf150-associated neoplasia. The differential methylation of the C6Orf150 nucleotide sequences has been observed in various forms of colon neoplasia, highlighting the potential for targeted therapies.
Career Highlights
Throughout her career, Myeroff has worked with prestigious institutions, including Case Western Reserve University and the University of Texas System. Her research has contributed to a deeper understanding of cancer biology and has implications for developing new diagnostic and therapeutic strategies.
Collaborations
Myeroff has collaborated with esteemed colleagues such as Sanford D. Markowitz and Helen Moinova, further enhancing the impact of her research in the scientific community.
Conclusion
Lois Myeroff's innovative work in cancer research exemplifies the importance of understanding genetic factors in disease. Her contributions continue to pave the way for advancements in cancer detection and treatment.